Clinical Trial Update: Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating IMM01-STEM versus placebo for improving muscle performance in seniors with obesity and muscle weakness. The study is currently A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenic Obesity

Drugs mentioned

• IMM01-STEM

Snippet

Sponsor: Immunis, Inc. | Conditions: Muscle Performance, Sarcopenic Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING